U S PHYSICAL THERAPY INC /NV
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $214.1M | $198.3M | $202.7M | $197.1M | $197.3M | $183.8M | $180.4M | $168.0M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $41.9M | $32.8M | $40.1M | $36.9M | $41.6M | $31.1M | $32.5M | $29.1M |
| Gross Margin | 19.6% | 16.5% | 19.8% | 18.7% | 21.1% | 16.9% | 18.0% | 17.3% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $19.0M | $18.3M | $18.1M | $17.4M | $17.5M | $16.2M | $15.6M | $14.4M |
| Operating Income | $21.9M | $12.5M | $16.8M | $25.3M | $24.9M | $19.6M | $19.7M | $12.8M |
| Operating Margin | 10.3% | 6.3% | 8.3% | 12.8% | 12.6% | 10.7% | 10.9% | 7.6% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $19.1M | $10.6M | $15.0M | $22.9M | $22.7M | $17.3M | $18.3M | $12.3M |
| Income Tax Expense | $4.2M | $2.4M | $5.8M | $5.2M | $4.9M | $3.9M | $5.8M | $2.6M |
| Net Income | $9.9M | $5.0M | $4.2M | $13.1M | $12.4M | $9.9M | $9.2M | $6.6M |
| Net Margin | 4.6% | 2.5% | 2.0% | 6.7% | 6.3% | 5.4% | 5.1% | 3.9% |
| EPS (Basic) | $0.25 | $-0.12 | $-0.44 | $0.48 | $0.58 | $0.80 | $0.52 | $0.39 |
| EPS (Diluted) | $0.25 | $-0.12 | $-0.44 | $0.48 | $0.58 | $0.80 | $0.52 | $0.39 |
| Shares Outstanding (Basic) | 15.1M | 15.2M | 15.2M | 15.2M | 15.2M | 15.1M | 15.1M | 15.1M |
| Shares Outstanding (Diluted) | 15.1M | 15.2M | 15.2M | 15.2M | 15.2M | 15.1M | 15.1M | 15.1M |
| Dividends Per Share | $0.46 | $0.46 | $0.45 | $0.45 | $0.45 | $0.45 | $0.44 | $0.44 |